多omics分析揭示了女性IBS患者的临床-肠-大脑相互作用,这些患者在童年时经历了不良经历
Michelle Binod1,2,3,4, Lin Chang5,6,7,8,9, Ming Wei Hung5,6,7,8,9
1Division of Pediatric Gastroenterology, Hepatology and Nutrition, UCLA, Los Angeles, CA, USA. MBinod@mednet.ucla.edu.
Biology of sex differences
|November 26, 2025
概括
刺激性肠综合征 (IBS) 的女性的不良童年经历 (ACE) 与明显的肠道细菌和大脑网络改变有关. 这项研究在高ACE女性中确定了IBS的多原子特征,提供了潜在的治疗点.
科学领域:
- 神经科学是一个神经科学.
- 胃肠病学 胃肠病学
- 微生物组研究 微生物组研究
背景情况:
- 大脑肠道系统促进双向通信,这对于应激反应至关重要.
- 刺激性肠综合征 (IBS) 是一种影响女性的压力敏感性疾病,与肠-大脑功能障碍有关.
- 儿童不良经历 (ACE) 通过放大压力反应,加剧IBS风险和严重程度.
研究的目的:
- 为了确定连接ACE暴露与女性IBS的多原子特征.
- 为了比较临床,神经成像和肠道微生物群特征在IBS女性高ACE和没有高ACE,与健康的对照 (HC).
主要方法:
- 分析了来自罗马阳性IBS患者和HC患者的数据,根据IBS诊断和ACE得分 (高ACE≥2,低ACE0-1) 将其分为四个子组.
- 通过转基因组学评估临床变量,多式脑 MRI 和肠道微生物功能.
- 使用 eXtreme梯度提升 (XGBoost) 进行特征识别和连接图进行多原子数据可视化.
主要成果:
- 高ACE的IBS女性报告说,与HC同行相比,抑郁症,焦虑,胃肠道症状焦虑,感知压力和体征症状增加.
- 在高ACE的IBS女性中,发现了有益细菌 (Akkermansia,Bifidobacterium) 和症状严重程度/ACE相关因素之间的负相关性.
- 一个组合模型准确地区分了高ACEIBS患者 (AUC=0.87,准确率=78%).
结论:
- 研究结果揭示了独特的微生物群和大脑网络,这些网络有助于早期生活压力女性的IBS病理生理学.
- 突出了慢性压力,脑肠微生物系统和IBS之间的复杂相互作用.
- 确定潜在的治疗目标,以减轻女性IBS患者早期生活压力的长期影响.
相关概念视频
Irritable Bowel Syndrome I: Introduction
899
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
899
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
718
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
718
Irritable Bowel Syndrome III: Medical and Nursing Management
617
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
617
Drugs for Treatment of Diarrhea-Predominant IBS
604
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
604
Chronic Bowel Disorders: Introduction
735
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
735
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
620
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
620


